Neurology Ionis Young Investigator Grant (YIG) – Cardiometabolic Program
Forecasted
The Neurology Ionis Young Investigator Grant funds innovative early-career research on Angelman Syndrome to advance understanding and patient care, supported by Ionis Pharmaceuticals.
Browse similar grants
Funder: Ionis Pharmaceuticals
Due Dates (Anticipated): May 2027 (Full application deadline, projected)
Funding Amounts: $50,000 per year for up to 2 years (second year contingent on progress)
Summary: Supports early-career researchers advancing Angelman Syndrome research and patient care, with competitive funding for fellows, residents, or junior faculty.
Key Information: Forecasted grant—dates and details subject to change; check program page for updates.
Description
The Neurology Ionis Young Investigator Grant (YIG) is designed to support early-career researchers conducting innovative translational, clinical, or applied research on Angelman Syndrome. Administered by the Neurology division within Ionis Medical Affairs, this competitive program aims to foster the development of emerging clinicians and scientists, encouraging research that advances the understanding, diagnosis, and care of Angelman Syndrome across diverse populations. The grant supports fellows, residents, or junior faculty at eligible academic or non-profit institutions, providing up to two years of funding (with the second year contingent on satisfactory research progress).
